Managing Colorectal Cancer Prevention Procedure Wait Lists During the COVID-19 Pandemic
Key facts
- Who runs it
- Centre hospitalier de l'Université de Montréal (CHUM)
- Where
- Canada1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Withdrawn
- Started
- Jun 2022
- Ended
- Dec 2023
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- colonoscopy
- FIT test
- CT colonography
- Record updated
- 29 November 2022
- Why it stopped
- The study was never started due to lack of staff
Who can take part
- Age
- 45 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- people with referral sheets for surveillance colonoscopies : meaning 3 or 5 years after the initial colonoscopy
Who cannot take part
- Crohn's disease
- familial polyposis syndrome
- patients with a personal history of CRC
- patients diagnosed with a CRC or a metastatic cancer
- patients with a history of contrast allergies
- known or suspected acute diverticulitis
- ulcerative colitis
- toxic megacolon
- acute abdominal pain
- coagulopathy
- poor general health (defined as an American Society of Anaesthesiologists class >3)
- patients presenting for emergency colonoscopies
- patients incapable of lying flat on their back for the duration of the CT colonography due CHF or other predispositions
- patient undergoing colonoscopy for surveillance after EMR or ESD procedures
- Patients referred for polypectomy
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The main objective of this study is to offer and evaluate an interim triage approach for patients waiting for surveillance colonoscopies. This will reduce the waiting period and the psychological stressors for our patients and from a scientific point of view allow us to compare the yield of findings for each approach.
The 3 groups in the trial
- a colonoscopy as surveillance examExisting treatment, for comparison
patients will undergo Colonoscopy, finding will be documented. Findings of colonoscopy will be documented and treated according to the institutional standards. Study participation for patients ends after the colonoscopy and follow-up of pathology results and complication assessment.
Treatment: colonoscopy
- undergoing a FIT as surveillance examExisting treatment, for comparison
if the FIT test is positive: patients will have subsequent colonoscopy within 3 months. Findings of FIT testing and if positive the colonoscopy will be documented and participation in the study will end after that. Findings of the FIT test and colonoscopy will be treated according to the institutional standards. If FIT test is negative patient will leave the study and will have a follow up with a colonoscopy or FIT test in 1 to 2 years outside of this study.
Treatment: FIT test
- undergoing CT colonography as surveillance examExisting treatment, for comparison
If CTC is positive: patients will have subsequent colonoscopy within 3 months. Findings will be documented and participation in the study will end there. Findings of the colonoscopy will be addressed according to our institution's guidelines. If CTC is negative for polypoid lesions patient will leave the study and will have a follow up 5 years after with either a CTC or colonoscopy.
Treatment: CT colonography
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 29 November 2022